110 related articles for article (PubMed ID: 32151650)
1. Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Stolzenbach F; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Urology; 2020 Jun; 140():91-97. PubMed ID: 32151650
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome predicts worse perioperative outcomes in patients treated with radical prostatectomy for non-metastatic prostate cancer.
Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Stolzenbach F; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Surg Oncol; 2021 Jun; 37():101519. PubMed ID: 33429324
[TBL] [Abstract][Full Text] [Related]
3. Predicted versus observed 30-day perioperative outcomes using the ACS NSQIP surgical risk calculator in patients undergoing partial nephrectomy for renal cell carcinoma.
Blair BM; Lehman EB; Jafri SM; Kaag MG; Raman JD
Int Urol Nephrol; 2018 Jul; 50(7):1249-1256. PubMed ID: 29868938
[TBL] [Abstract][Full Text] [Related]
4. Hypertension is the primary component of metabolic syndrome associated with pathologic features of kidney cancer.
Kocher NJ; Rjepaj C; Robyak H; Lehman E; Raman JD
World J Urol; 2017 Jan; 35(1):67-72. PubMed ID: 27189620
[TBL] [Abstract][Full Text] [Related]
5. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
Xu P; Wang J
J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
[No Abstract] [Full Text] [Related]
6. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors of overall and major postoperative complications after partial nephrectomy: Results from a multicenter prospective study (The RECORd 1 project).
Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Ficarra V; Fiori C; Furlan M; Giancane S; Longo N; Mirone V; Morgia G; Porpiglia F; Rovereto B; Schiavina R; Serni S; Simeone C; Volpe A; Carini M; Minervini A
Eur J Surg Oncol; 2017 Apr; 43(4):823-830. PubMed ID: 27876194
[TBL] [Abstract][Full Text] [Related]
8. Effects of metabolic syndrome on renal function after radical nephrectomy in patients with renal cell carcinoma.
Zhang Y; Wu T; Xie J; Yan L; Guo X; Xu W; Wang L
Int Urol Nephrol; 2021 Oct; 53(10):2127-2135. PubMed ID: 33459957
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
Tadewos A; Egeno T; Amsalu A
BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
11. Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer.
Luzzago S; Rosiello G; Pecoraro A; Deuker M; Stolzenbach F; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
Surg Oncol; 2021 Mar; 36():131-137. PubMed ID: 33401103
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Perioperative Morbidity and Mortality Rates of Minimally Invasive
Khalil MI; Ubeda J; Soehner T; Bhandari NR; Payakachat N; Davis R; Raheem OA; Kamel MH
J Endourol; 2019 Nov; 33(11):920-927. PubMed ID: 31333072
[No Abstract] [Full Text] [Related]
13. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
[TBL] [Abstract][Full Text] [Related]
14. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma.
Kang M; Gong IH; Park HJ; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Choi HY; Il Seo S
J Endourol; 2017 Dec; 31(12):1231-1236. PubMed ID: 29048228
[TBL] [Abstract][Full Text] [Related]
15. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Agudelo J; Stein R; Fareed K; Gao T; Fergany A; Kaouk J
J Urol; 2019 Jan; 201(1):56-61. PubMed ID: 30100402
[TBL] [Abstract][Full Text] [Related]
16. Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients.
Tang ZH; Wang L; Zeng F; Zhang K
BMC Cardiovasc Disord; 2014 Sep; 14():124. PubMed ID: 25249273
[TBL] [Abstract][Full Text] [Related]
17. Operative fusion of patients with metabolic syndrome increases risk for perioperative complications.
Pierce KE; Kapadia BH; Bortz C; Brown A; Alas H; Naessig S; Ahmad W; Vasquez-Montes D; Manning J; Wang E; Maglaras C; Raman T; Protopsaltis TS; Buckland AJ; Passias PG
J Clin Neurosci; 2020 Feb; 72():142-145. PubMed ID: 31899085
[TBL] [Abstract][Full Text] [Related]
18. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
19. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.
Vricella GJ; Finelli A; Alibhai SM; Ponsky LE; Abouassaly R
BJU Int; 2013 Jun; 111(8):1294-300. PubMed ID: 23368715
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
